• Thu, September 19, 2024

Emily Bodnar Maintained (BCTX) at Strong Buy with Decreased Target to $15 on, Sep 19th, 2024

Emily Bodnar of HC Wainwright & Co., Maintained "BriaCell Therapeutics Corp." (BCTX) at Strong Buy with Decreased Target from $18 to $15 on, Sep 19th, 2024.

Emily, nor any peers, have made any analyst calls on BCTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30